van Gageldonk PGM - Search Results

1

Prior exposure to B. pertussis shapes the mucosal antibody response to acellular pertussis booster vaccination.

van Schuppen E, Fröberg J, Venkatasubramanian PB, Versteegen P, de Graaf H, Holubová J, Gillard J, van Gageldonk PGM, Joosten I, de Groot R, Šebo P, Berbers GAM, Read RC, Huynen MA, de Jonge MI, Diavatopoulos DA. van Schuppen E, et al. Among authors: van gageldonk pgm. Nat Commun. 2022 Dec 2;13(1):7429. doi: 10.1038/s41467-022-35165-w. Nat Commun. 2022. PMID: 36460655 Free PMC article.

2

Blocking ELISA for detection of mumps virus antibodies in human sera.

Berbers GA, Marzec AH, Bastmeijer M, van Gageldonk PG, Plantinga AD. Berbers GA, et al. J Virol Methods. 1993 May;42(2-3):155-68. doi: 10.1016/0166-0934(93)90029-q. J Virol Methods. 1993. PMID: 8514838

3

Comparison of measles virus-specific antibody titres as measured by enzyme-linked immunosorbent assay and virus neutralisation assay.

van den Hof S, van Gageldonk-Lafeber AB, van Binnendijk RS, van Gageldonk PG, Berbers GA. van den Hof S, et al. Vaccine. 2003 Oct 1;21(27-30):4210-4. doi: 10.1016/s0264-410x(03)00490-0. Vaccine. 2003. PMID: 14505900

4

Epitope structure of the Bordetella pertussis protein P.69 pertactin, a major vaccine component and protective antigen.

Hijnen M, Mooi FR, van Gageldonk PG, Hoogerhout P, King AJ, Berbers GA. Hijnen M, et al. Infect Immun. 2004 Jul;72(7):3716-23. doi: 10.1128/IAI.72.7.3716-3723.2004. Infect Immun. 2004. PMID: 15213111 Free PMC article.

5

The Bordetella pertussis virulence factor P.69 pertactin retains its immunological properties after overproduction in Escherichia coli.

Hijnen M, van Gageldonk PG, Berbers GA, van Woerkom T, Mooi FR. Hijnen M, et al. Protein Expr Purif. 2005 May;41(1):106-12. doi: 10.1016/j.pep.2005.01.014. Protein Expr Purif. 2005. PMID: 15802227

6

The role of peptide loops of the Bordetella pertussis protein P.69 pertactin in antibody recognition.

Hijnen M, de Voer R, Mooi FR, Schepp R, Moret EE, van Gageldonk P, Smits G, Berbers GA. Hijnen M, et al. Vaccine. 2007 Aug 1;25(31):5902-14. doi: 10.1016/j.vaccine.2007.05.039. Epub 2007 Jun 8. Vaccine. 2007. PMID: 17597264

7

A novel strategy to mimic discontinuous protective epitopes using a synthetic scaffold.

Hijnen M, van Zoelen DJ, Chamorro C, van Gageldonk P, Mooi FR, Berbers G, Liskamp RM. Hijnen M, et al. Vaccine. 2007 Sep 17;25(37-38):6807-17. doi: 10.1016/j.vaccine.2007.06.027. Epub 2007 Jul 26. Vaccine. 2007. PMID: 17689841

8

Antibody responses to defined regions of the Bordetella pertussis virulence factor pertactin.

Hijnen M, He Q, Schepp R, Van Gageldonk P, Mertsola J, Mooi FR, Berbers GA. Hijnen M, et al. Scand J Infect Dis. 2008;40(2):94-104. doi: 10.1080/00365540701642138. Scand J Infect Dis. 2008. PMID: 17926203

9

Development and validation of a multiplex immunoassay for the simultaneous determination of serum antibodies to Bordetella pertussis, diphtheria and tetanus.

van Gageldonk PG, van Schaijk FG, van der Klis FR, Berbers GA. van Gageldonk PG, et al. J Immunol Methods. 2008 Jun 1;335(1-2):79-89. doi: 10.1016/j.jim.2008.02.018. Epub 2008 Mar 26. J Immunol Methods. 2008. PMID: 18407287

10

Immunity against Neisseria meningitidis serogroup C in the Dutch population before and after introduction of the meningococcal c conjugate vaccine.

de Voer RM, Mollema L, Schepp RM, de Greeff SC, van Gageldonk PG, de Melker HE, Sanders EA, Berbers GA, van der Klis FR. de Voer RM, et al. PLoS One. 2010 Aug 13;5(8):e12144. doi: 10.1371/journal.pone.0012144. PLoS One. 2010. PMID: 20730091 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

37 results

Search Page